PAYS Paysign, Inc.

Nasdaq paysign.com


$ 5.06 $ -0.10 (-1.94 %)    

Thursday, 20-Nov-2025 15:59:58 EST
QQQ $ 580.88 $ 0.00 (0 %)
DIA $ 458.33 $ 0.00 (0 %)
SPY $ 649.76 $ 0.00 (0 %)
TLT $ 89.74 $ 0.00 (0 %)
GLD $ 371.29 $ 0.00 (0 %)
$ 5.05
$ 5.32
$ 4.87 x 2
$ 5.03 x 10
-- - --
$ 1.80 - $ 8.88
607,936
na
277.97M
$ 1.47
$ 36.76
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-26-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-27-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-22-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-23-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-26-2021 12-31-2020 10-K
21 11-17-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 04-03-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-26-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-27-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-12-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 da-davidson-maintains-buy-on-paysign-maintains-9-price-target

DA Davidson analyst Peter Heckmann maintains PaySign (NASDAQ:PAYS) with a Buy and maintains $9 price target.

 paysign-raises-fy2025-gaap-eps-guidance-from-010-012-to-012-013-vs-012-est-raises-fy2025-sales-guidance-from-76500m-78500m-to-80500m-81500m-vs-77526m-est

PaySign (NASDAQ:PAYS) raises FY2025 GAAP EPS guidance from $0.10-$0.12 to $0.12-$0.13 vs $0.12 analyst estimate. Raises FY2025 ...

 paysign-q3-eps-004-beats-002-estimate-sales-21596m-beat-19916m-estimate

PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 81.8...

 paysign-opens-new-support-center-in-nevada-to-meet-surging-demand-for-patient-affordability-solutions

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement an...

 3-tech-infrastructure-stocks-look-ready-to-fly

3 software stocks, Intrusion, Katapult, & PaySign, surge in momentum rankings, signaling strong price performance in the se...

 lake-street-maintains-buy-on-paysign-raises-price-target-to-10

Lake Street analyst Jacob Stephan maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $9 to $10.

 paysign-sees-q3-sales-19500m-20500m-vs-18926m-est

PaySign (NASDAQ:PAYS) sees Q3 sales of $19.500 million-$20.500 million vs $18.926 million analyst estimate.

 paysign-sees-fy2025-gaap-eps-010-012-vs-012-est-raises-fy2025-sales-guidance-from-72000m-74000m-to-76500m-78500m-vs-75145m-est

PaySign (NASDAQ:PAYS) is looking for FY2025 GAAP EPS of $0.10-$0.12 vs $0.12 analyst estimate. Raises FY2025 sales outlook from...

 paysign-q2-eps-002-misses-004-estimate-sales-19078m-beat-18687m-estimate

PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.04 by 42...

 lake-street-maintains-buy-on-paysign-raises-price-target-to-9

Lake Street analyst Jacob Stephan maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $7 to $9.

 da-davidson-maintains-buy-on-paysign-raises-price-target-to-6

DA Davidson analyst Peter Heckmann maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $5 to $6.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION